Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 21 September 2023, 14:29 HKT/SGT
Share:
        

Source: Platohealth.ai / ClinicalSquared
Clinical Squared and PlatoHealth Join Forces to Revolutionize Healthcare with Advanced Data Orchestration Powered by AI

Clinical Squared (C2) and Platohealth.ai are delighted to announce a groundbreaking partnership that promises to reshape the healthcare landscape. Their collaboration brings together the healthcare expertise of C2 and the cutting-edge AI and machine learning capabilities of Plato.ai to create innovative solutions.

Clinical Squared, a leader in healthcare market expertise, data architecture, software development, consultation and implementation services, will lend its extensive industry knowledge to Plato.ai's platform. In turn, Plato.ai will provide advanced AI and machine learning mechanisms to enhance C2's products and services.

This strategic partnership aims to deliver more efficient and effective healthcare solutions for consumers, organizations and the broader healthcare ecosystem.

Marquis Allen, CEO of C2

"We are thrilled to partner with PlatoHealth.ai in our mission to transform healthcare experiences and outcomes using cutting-edge technology. Our collaboration represents a significant milestone for Clinical Squared as we leverage Plato.ai's superior AI capabilities to power our data navigation and orchestration tools for consumers and enterprises in the healthcare sector."

Bryan Feinberg, CEO of PlatoHealth

"This announcement comes at an opportune moment for both companies and we are excited to join forces with Clinical Squared to create transformative healthcare solutions powered by AI and machine learning. This partnership underscores our commitment to improving patient outcomes and healthcare processes. We look forward to the exciting innovations that will emerge from this collaboration."

Key Highlights of the Partnership:

Healthcare Expertise: Clinical Squared's deep healthcare domain expertise will enrich Plato.ai's AI models, ensuring that they are tailored to the specific needs of the healthcare industry.

Advanced AI: Plato.ai's advanced AI and machine learning mechanisms will be integrated into C2 products, enhancing their capabilities for healthcare organizations and technology users of varying skill levels

Innovation: The partnership aims to drive innovation in healthcare by developing solutions that provide security and portability of data as well as deep analytical context for users of the products they collaborate on.

Enhanced Patient Outcomes: By combining industry knowledge with AI-driven insights, the collaboration seeks to contribute to better patient outcomes and overall healthcare quality.

This partnership represents a significant step forward in the quest to harness the power of technology for the betterment of healthcare. Together, Clinical Squared and Plato.ai are committed to creating solutions that address the unique challenges of the healthcare industry, improving efficiency, and ultimately delivering better care to patients.

For more information about Clinical Squared and PlatoHealth.AI, please visit their respective websites:
Clinical Squared: https://www.clinicalsquared.com/about-us/
Plato.ai: https://Platohealth.ai

Contacts:

Bryan Feinberg
CEO, Plato Technologies Inc.
Zephyr@platodata.io

Marquis Allen
CEO, Clincial Squared
marquis.allen@clinicalsquared.com




Topic: Press release summary
Source: Platohealth.ai / ClinicalSquared

Sectors: Artificial Intel [AI], MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
OMP Positioned Highest for Both Completeness of Vision and Ability to Execute in the 2026 Gartner(R) Magic Quadrant(TM) for Supply Chain Planning Solutions: Process Industries  
Mar 23, 2026 23:15 HKT/SGT
Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders  
Mar 23, 2026 21:05 HKT/SGT
Essex Bio-Technology Reports Robust Results for FY2025, Turnover Soars 8.6% to HK$1814 million, Net Profit up 3.5% to HK$ 318.1 million, Total Dividend Increases by 16.7% to HK14 Cents per Share  
Mar 23, 2026 20:51 HKT/SGT
GMG Launches European Sales Team; G(R) Lubricant Patent Accepted for Europe  
Mar 23, 2026 20:29 HKT/SGT
Everest Medicines Enters into Asset Purchase Agreement for Etripamil Nasal Spray, Expanding Cardiovascular Footprint  
Mar 23, 2026 18:59 HKT/SGT
From SGD to Global Spending: How Singaporeans Can Avoid FX Fees While Travelling Overseas  
Mar 23, 2026 14:15 HKT/SGT
Fujitsu-developed traffic simulation system utilized in Maebashi City's public transportation planning  
Monday, March 23, 2026 1:24:00 PM
Hitachi Receives the 2026 Catalyst Award, a Global Recognition for Building an Inclusive Organization   
Monday, March 23, 2026 10:49:00 AM
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026  
Monday, March 23, 2026 10:19:00 AM
Unitree Robotics IPO Ignites Embodied-Intelligence Rally, Shoucheng Holdings (0697.HK) Faces a Dual Catalyst of 'Investment Realisation+Platform Re-Rating'  
Mar 23, 2026 08:22 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: